Correction: Hansa Biopharma Nomination Committee formed
The correction only concerns the removal of the reference to the EU Market Abuse Regulation that was incorrectly included in the original press release, distributed at 8am on December 23, 2022. Lund, December 28, 2022. Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on June 30, 2022 and has the following composition: · Natalie Berner representing Redmile Group · Jannis Kitsakis representing AP4 · Arne Myhrman representing Thomas Olausson As the conveyer of the